Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Novel therapeutic options for multiple sclerosis.
Relapsing-remitting multiple sclerosis: patterns of response to disease-modifying therapies and associated factors: a national survey.
Exercise as a therapy for improvement of walking ability in adults with multiple sclerosis: A meta-analysis.
Implications for multiple sclerosis in the era of the Affordable Care Act: the shifting managed care landscape.
A descriptive study of prevalence, clinical features and other findings of neuromyelitis optica and neuromyelitis optica spectrum disorder in Khuzestan Province, Iran.
condition Specific Utilities: Impact on Icer in a Markov Model for Multiple Sclerosis.
Impaired retinal microcirculation in multiple sclerosis.
Depression in multiple sclerosis: effect of brain derived neurotrophic factor Val66Met polymorphism and disease perception.
Spatio-Temporal Patterns of Demyelination and Remyelination in the Cuprizone Mouse Model.
Dysregulation of ErbB Receptor Trafficking and Signaling in Demyelinating Charcot-Marie-Tooth Disease.
From Identification to Characterization of the Multiple Sclerosis Susceptibility Gene CLEC16A.
Mesenchymal stem cells of dental origin - their potential for anti-inflammatory and regenerative actions in brain and gut damage.
Association of Autophagy in the Cell Death Mediated by Dihydrotestosterone in Autoreactive T Cells Independent of Antigenic Stimulation.
Clinical perspectives on medical marijuana (cannabis) for neurologic disorders.
Perspectives on neuroreparative therapies for treating multiple sclerosis.
Challenging AQP4 druggability for NMO-IgG antibody binding using molecular dynamics and molecular interaction fields.
Influence of multiple sclerosis, age and degree of disability, in the position of the contrast sensitivity curve peak.
Virtual Sensory Feedback for Gait Improvement in Neurological Patients.
Nurse-led clinics for patients with chronic diseases in hospital and transmural care organizations.
Mesenchymal stem cells attenuate MRI-identifiable injury, protect white matter, and improve long-term functional outcomes after neonatal focal stroke in rats.
Future of management of multiple sclerosis in the middle East: a consensus view from specialists in ten countries.
[Effective rehabilitation of hospitalized patients with multiple sclerosis].
Increased Signal Intensity in the Dentate Nucleus of Patients with Multiple Sclerosis in Comparison with Neuromyelitis Optica Spectrum Disorder after Multiple Doses of Gadolinium Contrast.
Anti-MOG antibody: The history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination.
Ubiquitin-independent proteosomal degradation of myelin basic protein contributes to development of neurodegenerative autoimmunity.
Pages
« first
‹ previous
…
628
629
630
631
632
633
634
635
636
…
next ›
last »